CFO interim
Cadrenal Therapeutics, Inc. names John P. Sharp interim CFO
Cadrenal Therapeutics, Inc. reported in a Form 8-K filed June 29, 2026 that John P. Sharp was named interim Interim Chief Financial Officer, effective June 25, 2026.
In the filing's words
On June 25, 2026, the Board of Directors (the “Board”) of Cadrenal Therapeutics, Inc. (the “Company”) appointed John P. Sharp as Interim Chief Financial Officer of the Company. In connection with the appointment, Quang X. Pham ceased to serve as the Company’s Interim Chief Financial Officer.
Verbatim from sec.gov, Item 5.02. We quote departures; we do not characterize them.
| Company | Cadrenal Therapeutics, Inc. (CVKD) |
|---|---|
| Event | Interim |
| Incoming | John P. Sharp |
| Outgoing | Quang X. Pham |
| Title in the filing | Interim Chief Financial Officer |
| Effective | June 25, 2026 |
| 8-K filed | June 29, 2026 |
| Internal promotion | No |
| Prior role (per filing) | Senior Director, Lohman & Associates |
| SEC CIK | 0001937993 |
Cadrenal Therapeutics, Inc. reported this change in a Form 8-K, Item 5.02, filed June 29, 2026. The filing's own words are quoted above.
Sources
- sec.gov · SEC filing, Item 5.02 · accessed 2026-09-26
Something wrong about John P. Sharp? Send a correction with the primary source.